NeuroMetrix Announces Highly Positive Industry and Media Reaction To Quell Wearable Pain Relief Technology At The 2016 Consumer Electronics Show

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) announced a high level of interest in Quell, the company’s over-the-counter, 100% drug free chronic pain relief wearable at CES 2016. Highlights of the Week include:

Quell was selected as one of 10 finalists in the CES Last Gadget Standing competition

NeuroMetrix was selected to participate in two panel discussions – “The Roadmap to FDA Approval” and “The Future of Wearables”